Paclitaxel Drug Coated Balloon
OVERVIEW For Paclitaxel Drug Coated Balloon
The Drug coating dilation balloon catheter specifically designed and exclusively CFDA approved high pressure DCB for the treatment of shunt stenosis.
FLOWTY DCB protects AV fistulas and shunt grafts from early restenosis.
For the prevention and successful dilatation of intimal hyperplasia.
INDICATIONS forPaclitaxel Drug Coated Balloon
FLOWTY DCB is suitable for new generation, restenosis or stent restenosis of superficial femoral artery or popliteal artery, and the reference vessel diameter is 4-7mm.A drug on a balloon is released into the blood vessel to treat a narrow lesion.
PRODUCT DETAILS for Drug eluting Balloon
Shunt restenosis represents a common threat to the function of arteriovenous fistulas (AVFs) and shunt grafts in patients on hemodialysis. Patients often develop a consecutive neointimal hyperplasia in hemodialysis access vessels as well as along the needle puncture site.
The new APERTO DCB Paclitaxel releasing, high pressure balloon dilatation catheter provides a dual shunt treatment quality for the prevention and dilatation of intimal hyperplasia. AVF or PTFE shunt graft venous outflow lesions can be treated very successfully by the new APERTO OTW leading to a substantial reduction of hemodialysis shunt restenosis, for a prolonged dialysis access survival
PRODUCT FEATUURES of Drug eluting Balloon
FLOWTY Paclitaxel Nano-needle Crystal Coating Technology
1.Innovative drug coating technology realizes effective release and absorption of paclitaxel
Nanosized crystals greatly reduce the probability of distal vascular microembolism, further ensuring safety
2. Paclitaxel was uniformly sprayed on the surface of bare balloon by ultrasonic atomization.
Innovative drug coating technology controls the crystal morphology and particle size of paclitaxel on balloon surface
3.The drug coating of paclitaxel on the surface of the balloon is uniform, compact and firm, and the drug loss is low during transportation.
Drug nano needle-like crystal diameter ≤300nm, particle size is very small, easy to penetrate the intima and quickly transfer to the vascular wall, improve drug absorption rate, and form a micro-reservoir for slow release of drugs, maintain effective concentration for a long time, and continue to inhibit intima hyperplasia.
Reduces potential particulate concerns and reduces the risk of distal embolism.
Previous drug balloon clinical pain points
Distal microvascular embolism
The coating particles are too large, and the large particles fall off during elution, resulting in distal microvascular embolism
Contrast excipients tend to cause vascular inflammation, resulting in distal microvascular embolism
Low drug absorption rate
Too many drugs are lost during balloon delivery
Hydrophilic excipients inhibit drug transfer and absorption to some extent
The drug is washed away by the blood stream to the distal end of the vessel before it can be transferred to the vessel wall
Our Services
1. Good knowledge on different market can meet special requirements.
2. Real manufacturer with our own factory located in Hangzhou China
3. Strong professional technical team ensure to produce the top quality products.
4. Special cost control system ensure to provide the most favorable price.
5. Rich experience on outdoor equipment.
CONTACT WAY
Name: Eiffel Lu
Email: LLLU@batymedical.com
Mobile: +86 182 2165 9426 (whatsapp)
- Step 1Find your interested products by search keywords
- Step 2Contact the supplier by clicking ”Enquire” or “request meeting” button, otherwise, you also could consult our import consultant.
- Step 3After verifying your email, get response from suppliers or our trade manager will contact you as soon as possible
- Step 4Set up meeting with the Chinese supplier without language barrier
